What is Wegovy?
Wegovy is Novo Nordisk's brand semaglutide, FDA-approved for chronic weight management in adults with obesity, or overweight with a weight-related condition, alongside diet and exercise, and to reduce cardiovascular risk in adults with obesity or overweight and established heart disease. It comes as a weekly injection pen, and some providers now list the once-daily Wegovy pill. Ozempic is the same medication approved for type 2 diabetes.
Who offers brand access right now
| Brand Picture | Right Now |
|---|---|
| Providers with brand semaglutide plans | 25 of 73 providers |
| Median monthly, lowest-priced dose | $208 |
| Full range, all doses | $25 to $1839 |
| Pricing last verified | 2026-07-08 |
These plans cover brand semaglutide access as providers publish it, Wegovy or Ozempic, with the all-in monthly total including required fees. Brand access comes in two shapes, and the range reflects both: at the low end are plans priced as a visit membership, with the medication billed separately through insurance or the pharmacy, while plans that include the medication in the price sit higher. The comparison list shows every plan with its price and state availability.
Brand cost by dose
Brand plans are priced by dose like the label's own tiers. Each provider counts once per dose here, at its lowest all-in monthly price for that dose.
| Weekly Dose | Providers | Median Monthly |
|---|---|---|
| 0.25 mg | 24 | $307 |
| 0.5 mg | 22 | $307 |
| 1 mg | 22 | $388 |
| 1.7 mg | 21 | $374 |
| 2.4 mg | 21 | $374 |
Ways to get Wegovy
- Telehealth programs: the providers tracked here bundle the prescription visit with brand fulfillment, and their plans appear in the directory with all-in pricing.
- NovoCare Pharmacy: Novo Nordisk sells Wegovy directly at published self-pay prices, with the prescription written by your own prescriber or through its telehealth partners.
- Insurance: coverage varies by plan and runs through the weight-management or cardiovascular indications. Each plan's card here shows which fees its total carries.
Wegovy and compounded semaglutide
Compounded plans are a pricing alternative to the brand versions, intended to contain the same active ingredient, though compounded versions are not FDA-approved or verified as equivalent. Both paths appear side by side in the directory.
This page is a general reference, not medical advice. Whether Wegovy fits your situation, and the dose, is a decision for you and a licensed prescriber, guided by the FDA label.
Sources: the FDA-approved Wegovy label and Novo Nordisk's published product details, and each provider's own published pages, re-verified on a rolling schedule. Price figures are computed live from the same verified data as the comparison tool, most recently confirmed on the date shown above.